US Stock MarketDetailed Quotes

MCRB Seres Therapeutics

Watchlist
  • 0.812
  • +0.005+0.56%
Close Nov 5 16:00 ET
138.19MMarket Cap-682P/E (TTM)

Seres Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
1,672.24%126.33M
-93.44%64K
-91.00%310K
10,300.74%126.47M
-134.96%-522K
-95.08%7.13M
-88.24%975K
-97.28%3.44M
Operating revenue
--0
--0
1,672.24%126.33M
-93.44%64K
-91.00%310K
10,300.74%126.47M
-134.96%-522K
-95.08%7.13M
-88.24%975K
-97.28%3.44M
Cost of revenue
Gross profit
Operating expense
-59.27%31.35M
-43.49%39.59M
-7.61%234.31M
-42.86%39.59M
-23.71%47.72M
19.22%76.95M
22.36%70.05M
21.10%253.62M
20.02%69.28M
7.26%62.55M
Selling and administrative expenses
-42.75%16.06M
-31.17%15.47M
10.10%87.74M
-23.08%17.23M
8.73%19.99M
37.94%28.05M
21.00%22.47M
15.06%79.69M
9.26%22.4M
-6.03%18.38M
-General and administrative expense
-42.75%16.06M
-31.17%15.47M
10.10%87.74M
-23.08%17.23M
8.73%19.99M
37.94%28.05M
21.00%22.47M
15.06%79.69M
9.26%22.4M
-6.03%18.38M
Research and development costs
-61.80%17.88M
-50.64%21.7M
-15.65%145.86M
-41.92%26.85M
-34.47%28.25M
6.50%46.79M
10.90%43.97M
21.87%172.92M
25.76%46.22M
8.11%43.12M
Other operating expenses
-222.93%-2.59M
-32.96%2.42M
-29.88%704K
-782.37%-4.49M
-149.38%-519K
677.12%2.11M
469.57%3.61M
157.97%1M
41.51%658K
193.26%1.05M
Operating profit
-163.29%-31.35M
43.90%-39.59M
56.19%-107.98M
42.13%-39.53M
19.78%-47.41M
178.21%49.52M
-26.58%-70.57M
-282.20%-246.49M
-38.18%-68.31M
-186.40%-59.11M
Net non-operating interest income expense
-51.75%-2.22M
-229.15%-3.02M
-98.35%-5.88M
-341.63%-2.06M
-67.05%-1.44M
-32.10%-1.46M
-73.48%-916K
-7,305.00%-2.96M
-84.19%-466K
-459.74%-862K
Non-operating interest income
-28.74%1.23M
59.69%1.65M
138.75%7.3M
39.39%1.97M
197.34%2.57M
336.96%1.73M
168.75%1.03M
6.55%3.06M
191.55%1.41M
46.61%865K
Non-operating interest expense
8.16%3.45M
139.37%4.66M
118.87%13.18M
114.31%4.03M
132.31%4.01M
112.33%3.19M
113.60%1.95M
106.87%6.02M
154.74%1.88M
132.12%1.73M
Other net income (expense)
145.80%692K
696.13%2.47M
119.01%134K
1,560.87%336K
3,127.27%999K
-397.04%-1.51M
189.86%310K
32.54%-705K
92.72%-23K
5.71%-33K
Other non- operating income (expenses)
145.80%692K
696.13%2.47M
119.01%134K
1,560.87%336K
3,127.27%999K
-397.04%-1.51M
189.86%310K
32.54%-705K
92.72%-23K
5.71%-33K
Income before tax
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
-187.96%-60M
Income tax
Net income
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
-187.96%-60M
Net income continuous Operations
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
-187.96%-60M
Minority interest income
Net income attributable to the parent company
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
-187.96%-60M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-170.61%-32.87M
43.61%-40.13M
54.54%-113.72M
40.04%-41.25M
20.25%-47.85M
171.91%46.55M
-25.70%-71.17M
-281.46%-250.16M
-37.59%-68.8M
-187.96%-60M
Basic earnings per share
-161.11%-0.22
52.63%-0.27
61.47%-0.89
40.74%-0.32
24.49%-0.37
151.43%0.36
6.56%-0.57
-220.83%-2.31
1.82%-0.54
-166.22%-0.49
Diluted earnings per share
-161.11%-0.22
52.63%-0.27
61.47%-0.89
40.74%-0.32
24.49%-0.37
151.43%0.36
6.56%-0.57
-220.83%-2.31
1.82%-0.54
-168.06%-0.49
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 001,672.24%126.33M-93.44%64K-91.00%310K10,300.74%126.47M-134.96%-522K-95.08%7.13M-88.24%975K-97.28%3.44M
Operating revenue --0--01,672.24%126.33M-93.44%64K-91.00%310K10,300.74%126.47M-134.96%-522K-95.08%7.13M-88.24%975K-97.28%3.44M
Cost of revenue
Gross profit
Operating expense -59.27%31.35M-43.49%39.59M-7.61%234.31M-42.86%39.59M-23.71%47.72M19.22%76.95M22.36%70.05M21.10%253.62M20.02%69.28M7.26%62.55M
Selling and administrative expenses -42.75%16.06M-31.17%15.47M10.10%87.74M-23.08%17.23M8.73%19.99M37.94%28.05M21.00%22.47M15.06%79.69M9.26%22.4M-6.03%18.38M
-General and administrative expense -42.75%16.06M-31.17%15.47M10.10%87.74M-23.08%17.23M8.73%19.99M37.94%28.05M21.00%22.47M15.06%79.69M9.26%22.4M-6.03%18.38M
Research and development costs -61.80%17.88M-50.64%21.7M-15.65%145.86M-41.92%26.85M-34.47%28.25M6.50%46.79M10.90%43.97M21.87%172.92M25.76%46.22M8.11%43.12M
Other operating expenses -222.93%-2.59M-32.96%2.42M-29.88%704K-782.37%-4.49M-149.38%-519K677.12%2.11M469.57%3.61M157.97%1M41.51%658K193.26%1.05M
Operating profit -163.29%-31.35M43.90%-39.59M56.19%-107.98M42.13%-39.53M19.78%-47.41M178.21%49.52M-26.58%-70.57M-282.20%-246.49M-38.18%-68.31M-186.40%-59.11M
Net non-operating interest income expense -51.75%-2.22M-229.15%-3.02M-98.35%-5.88M-341.63%-2.06M-67.05%-1.44M-32.10%-1.46M-73.48%-916K-7,305.00%-2.96M-84.19%-466K-459.74%-862K
Non-operating interest income -28.74%1.23M59.69%1.65M138.75%7.3M39.39%1.97M197.34%2.57M336.96%1.73M168.75%1.03M6.55%3.06M191.55%1.41M46.61%865K
Non-operating interest expense 8.16%3.45M139.37%4.66M118.87%13.18M114.31%4.03M132.31%4.01M112.33%3.19M113.60%1.95M106.87%6.02M154.74%1.88M132.12%1.73M
Other net income (expense) 145.80%692K696.13%2.47M119.01%134K1,560.87%336K3,127.27%999K-397.04%-1.51M189.86%310K32.54%-705K92.72%-23K5.71%-33K
Other non- operating income (expenses) 145.80%692K696.13%2.47M119.01%134K1,560.87%336K3,127.27%999K-397.04%-1.51M189.86%310K32.54%-705K92.72%-23K5.71%-33K
Income before tax -170.61%-32.87M43.61%-40.13M54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M-187.96%-60M
Income tax
Net income -170.61%-32.87M43.61%-40.13M54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M-187.96%-60M
Net income continuous Operations -170.61%-32.87M43.61%-40.13M54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M-187.96%-60M
Minority interest income
Net income attributable to the parent company -170.61%-32.87M43.61%-40.13M54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M-187.96%-60M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -170.61%-32.87M43.61%-40.13M54.54%-113.72M40.04%-41.25M20.25%-47.85M171.91%46.55M-25.70%-71.17M-281.46%-250.16M-37.59%-68.8M-187.96%-60M
Basic earnings per share -161.11%-0.2252.63%-0.2761.47%-0.8940.74%-0.3224.49%-0.37151.43%0.366.56%-0.57-220.83%-2.311.82%-0.54-166.22%-0.49
Diluted earnings per share -161.11%-0.2252.63%-0.2761.47%-0.8940.74%-0.3224.49%-0.37151.43%0.366.56%-0.57-220.83%-2.311.82%-0.54-168.06%-0.49
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data